Vaxil Bio CoronaVirus Vaccine Candidate and Cancer treatment @dom that article about Vaxil Bio dated May 2012 is super interesting and could possibly provide a "double whammy " here anytime . Here is the important excerpt :
"Though the results from the small study are impressive, ImMucin is years away from commercial production," Griffin stated. "Further clinical trials and a lengthy approval and regulatory process will delay the commercial production of the vaccine. However, ImMucin is expected to hit the shelves as early as 2020."
ImMucin may be used independently or in combination with other cancer treatments, and may be used after certain procedures, such as radiation or surgery, to prevent future tumors from growing, she wrote.
"For such cancers that do not respond well to traditional treatment options, ImMucin offers hope," Griffin said. "ImMucin triggers the body's natural defense mechanism—the immune system—to recognize the sugary molecule known as MUC1 and destroys the tumor. Even cancers as rare as multiple myeloma—the test group—contain the MUC1 molecule like mesothelioma, a deadly disease linked to chronic asbestos exposure, a toxin used in manufacturing."
The applications of ImMucin for difficult or rare cancers "are limitless: further malignancies can be stopped, inoperable tumors can be slowed and the complete cessation of the disease," she added.
https://ddn-news.com/index.php?newsarticle=6140